Novavax says FDA put hold on combination Covid-flu shot and influenza vaccine; shares plunge

Share This Post

The so-called clinical hold is due to a single report of nerve damage in a patient who received the combination shot in a phase two trial.

Subscribe The Newsletter

Get updates and learn from the best

More To Explore

Do You Want To Stay Connected?

drop a line and keep in touch